Endocrinology. Does growth hormone-releasing factor assist follicular development in poor responder patients undergoing ovarian stimulation for in-vitro fertilization?

By Howles C.M.  

Human Reproduction, Vol. 14, Iss. 8, 1999-08 ,pp. : 1939-1943

Oxford University Press

Access to resources Recommend Favorite

Dual suppression with oral contraceptives and gonadotrophin releasing-hormone agonists improves in-vitro fertilization outcome in high responder patients

By Damario M.A.   Barmat L.   Liu H.-C.   Davis O.K.   Rosenwaks Z.  

Human Reproduction, Vol. 12, Iss. 11, 1997-11 ,pp. : 2359-2365

Oxford University Press

Access to resources Recommend Favorite

Endocrinology. Recombinant follicle stimulating hormone in in-vitro fertilization treatment—clinical experience with follitropin alpha and follitropin beta

By Harlin Jonas   Csemiczky G.   Wramsby H.  

Human Reproduction, Vol. 15, Iss. 2, 2000-02 ,pp. : 239-244

Oxford University Press

Access to resources Recommend Favorite

Endocrinology. Monoclonal gammopathy may disturb oestradiol measurement in the treatment and monitoring of in-vitro fertilization: Case report

By Kairemo K.J.A.  

Human Reproduction, Vol. 14, Iss. 11, 1999-11 ,pp. : 2724-2726

Oxford University Press

Access to resources Recommend Favorite

In vitro fertilization stimulation protocol for normal responder patients

By Marci R.   Caserta D.   Lisi F.   Graziano A.   Soave I.   Lo Monte G.   Patella A.   Moscarini M.  

Gynecological Endocrinology, Vol. 29, Iss. 2, 2013-02 ,pp. : 109-112

Informa Healthcare

Access to resources Recommend Favorite